[go: up one dir, main page]

CU23406A1 - Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias - Google Patents

Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias

Info

Publication number
CU23406A1
CU23406A1 CU20020275A CU20020275A CU23406A1 CU 23406 A1 CU23406 A1 CU 23406A1 CU 20020275 A CU20020275 A CU 20020275A CU 20020275 A CU20020275 A CU 20020275A CU 23406 A1 CU23406 A1 CU 23406A1
Authority
CU
Cuba
Prior art keywords
treatment
human antibodies
infections
containing human
micobacteries
Prior art date
Application number
CU20020275A
Other languages
English (en)
Inventor
Lahenz Armando Cadiz
Benitez Maximo Berto Martinez
Bourzac Juan Francisco Infante
Hernandez Yamile Lopez
Garcia San Miguel Maria Elena Sarmiento
Diaz Gustavo Falero
Dominguez Armando Acosta
Gonzalez Victoriano Gustavo Sierra
Original Assignee
Inst Finlay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay filed Critical Inst Finlay
Priority to CU20020275A priority Critical patent/CU23406A1/es
Priority to MYPI20034528A priority patent/MY143402A/en
Priority to BR0316558-2A priority patent/BR0316558A/pt
Priority to CA002507338A priority patent/CA2507338A1/en
Priority to US10/536,298 priority patent/US20060222642A1/en
Priority to DE60324466T priority patent/DE60324466D1/de
Priority to PCT/CU2003/000015 priority patent/WO2004047865A1/es
Priority to CN200380109162A priority patent/CN100579581C/zh
Priority to AU2003285261A priority patent/AU2003285261A1/en
Priority to ARP030104344A priority patent/AR042140A1/es
Priority to RU2005119995/15A priority patent/RU2350352C2/ru
Priority to MXPA05005669A priority patent/MXPA05005669A/es
Priority to EP03778232A priority patent/EP1582218B1/en
Priority to ZA200504773A priority patent/ZA200504773B/en
Publication of CU23406A1 publication Critical patent/CU23406A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con el campo de la inmunología, específicamente con el control de enfermedades infecciosas causadas por micobacterias, basada en la obtención de preparaciones conteniendo anticuerpos humanos, administrados a través de mucosas y otras vías, las cuales tienen efecto profiláctico y terapéutico. Preparaciones de IgG e IgA, incluyendo IgA secretoria o mezclas de las mismas con actividad específica contra antígenos microbacterianos se han desarrollado para ser aplicados en la prevencióno tratamiento de infecciones producidas por este tipo de microorganismos. Dichas formulaciones han probado su efectividad en la inhibición "in vivo" de infecciones producidas por microbacterias.
CU20020275A 2002-11-25 2002-11-25 Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias CU23406A1 (es)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CU20020275A CU23406A1 (es) 2002-11-25 2002-11-25 Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias
MYPI20034528A MY143402A (en) 2002-11-25 2003-11-24 Preparations used in the treatment and prophilaxis of mycobacterial infections
BR0316558-2A BR0316558A (pt) 2002-11-25 2003-11-25 Composição contra micobactérias e seu uso
CA002507338A CA2507338A1 (en) 2002-11-25 2003-11-25 Compositions for the treatment of mycobacterial infections
US10/536,298 US20060222642A1 (en) 2002-11-25 2003-11-25 Compositions for the treatment of mycobacterial infections
DE60324466T DE60324466D1 (de) 2002-11-25 2003-11-25 Zusammensetzungfür die behandlung von mycobakterieninfektionen
PCT/CU2003/000015 WO2004047865A1 (es) 2002-11-25 2003-11-25 Composiciones para el tratamiento de infecciones por micobacterias
CN200380109162A CN100579581C (zh) 2002-11-25 2003-11-25 用于治疗分枝杆菌感染的组合物
AU2003285261A AU2003285261A1 (en) 2002-11-25 2003-11-25 Compositions for the treatment of mycobacterial infections
ARP030104344A AR042140A1 (es) 2002-11-25 2003-11-25 Composiciones para el tratamiento y profilaxis de infecciones por micobacterias
RU2005119995/15A RU2350352C2 (ru) 2002-11-25 2003-11-25 Препараты, содержащие антитела человека, применяемые в лечении микобактериальных инфекций
MXPA05005669A MXPA05005669A (es) 2002-11-25 2003-11-25 Composiciones que contienen anticuerpos humanos para el tratamiento de infecciones por micobacterias.
EP03778232A EP1582218B1 (en) 2002-11-25 2003-11-25 Compositions for the treatment of mycobacterial infections
ZA200504773A ZA200504773B (en) 2002-11-25 2005-06-10 Compositions for the treatment of mycobacterial infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020275A CU23406A1 (es) 2002-11-25 2002-11-25 Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias

Publications (1)

Publication Number Publication Date
CU23406A1 true CU23406A1 (es) 2009-08-04

Family

ID=32331941

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20020275A CU23406A1 (es) 2002-11-25 2002-11-25 Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias

Country Status (14)

Country Link
US (1) US20060222642A1 (es)
EP (1) EP1582218B1 (es)
CN (1) CN100579581C (es)
AR (1) AR042140A1 (es)
AU (1) AU2003285261A1 (es)
BR (1) BR0316558A (es)
CA (1) CA2507338A1 (es)
CU (1) CU23406A1 (es)
DE (1) DE60324466D1 (es)
MX (1) MXPA05005669A (es)
MY (1) MY143402A (es)
RU (1) RU2350352C2 (es)
WO (1) WO2004047865A1 (es)
ZA (1) ZA200504773B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1664119A1 (en) 2003-09-08 2006-06-07 Medical Research Council Method for the treatment or prophylaxis of tuberculosis
JP6410601B2 (ja) 2012-02-29 2018-10-24 大塚製薬株式会社 抗リポアラビノマンナン抗体及び当該抗体を用いた抗酸菌症のイムノアッセイ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816563A (en) * 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
US20010007660A1 (en) * 1997-06-04 2001-07-12 Aharona Glatman-Freedman Methods of treating and protecting against tuberculosis using a monoclonal antibody selective for mycobacterium tuberculosis
WO1998057993A1 (en) * 1997-06-19 1998-12-23 The Regents Of The University Of California Secretory immunoglobulin produced by single cells and methods for making and using same

Also Published As

Publication number Publication date
CN1756565A (zh) 2006-04-05
AU2003285261A1 (en) 2004-06-18
MY143402A (en) 2011-05-13
AR042140A1 (es) 2005-06-08
US20060222642A1 (en) 2006-10-05
CA2507338A1 (en) 2004-06-10
EP1582218A1 (en) 2005-10-05
WO2004047865A1 (es) 2004-06-10
RU2350352C2 (ru) 2009-03-27
MXPA05005669A (es) 2006-02-22
RU2005119995A (ru) 2006-03-20
CN100579581C (zh) 2010-01-13
ZA200504773B (en) 2007-12-27
EP1582218B1 (en) 2008-10-29
BR0316558A (pt) 2005-10-04
DE60324466D1 (de) 2008-12-11

Similar Documents

Publication Publication Date Title
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
AR012304A1 (es) Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
PT1326635E (pt) Composicao farmaceutica para imunizacao contra a sida
BR0316906A (pt) administração do capsaicinoides
MY145790A (en) Composition
ES2156028T3 (es) Composiciones que contienen tetrahidrolipstatina
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
DK1792610T3 (da) Terapeutiske bioadhæsive systemet med langvarig frigivelse
PA8657201A1 (es) Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
BR0206362A (pt) Produto para tratamento de lentes de contato contendo dexpantenol
WO2007140011A3 (en) Erythroid progenitor cells and methods for producing parvovirus b19 therein
AR036937A1 (es) Tableta masticable que contiene lisina
CU23406A1 (es) Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias
AR027937A1 (es) Tratamiento de condiciones alergicas e inflamatorias
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BR0212232A (pt) Agente antiinfluenza
PT1049480E (pt) Agente herbaceo antiviral
BR0210910A (pt) Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal
UY26945A1 (es) Alcanosulfonatos de fenoxifenilo
NZ547521A (en) Protein NMB0928 and use thereof in pharmaceutical formulations
ES2916650A1 (es) Medio de tratamiento antiinfeccioso para humanos o animales (procedimiento de fabricación y uso)
ES2382845A1 (es) Mejoras introducidas en la patente principal p200400524 por "composición líquida natural contra infecciones".